Metabolism of 3-nitrophenol by the frog Rana temporaria. 1986

G Frank, and J Beyer

Frogs injected with 3-nitrophenol excreted 85-93% of the administered dose within 17 h; 70-90% dose was metabolized. Metabolites identified comprise 3-nitrophenyl glucuronide (57% dose), 3-nitrophenyl sulphate (24% dose), and 3-acetamidophenyl sulphate (2% dose). Traces of the following metabolites were found: 3-acetamidophenyl glucuronide, 3-acetamidophenol, 4-nitrocatechol, nitroquinol, 4-nitrocatechol sulphate and nitroquinol sulphate.

UI MeSH Term Description Entries
D009596 Nitrophenols PHENOLS carrying nitro group substituents. Nitrophenol
D011896 Rana temporaria A species of the family Ranidae occurring in a wide variety of habitats from within the Arctic Circle to South Africa, Australia, etc. European Common Frog,Frog, Common European,Common European Frog,Common Frog, European,European Frog, Common,Frog, European Common
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

G Frank, and J Beyer
August 1973, General and comparative endocrinology,
G Frank, and J Beyer
June 1972, Comparative and general pharmacology,
G Frank, and J Beyer
January 1992, Zhurnal evoliutsionnoi biokhimii i fiziologii,
G Frank, and J Beyer
June 2023, Emerging infectious diseases,
G Frank, and J Beyer
January 1984, Zhurnal evoliutsionnoi biokhimii i fiziologii,
G Frank, and J Beyer
June 1966, Journal of morphology,
G Frank, and J Beyer
January 1984, Immunogenetics,
G Frank, and J Beyer
March 1968, The American journal of physiology,
G Frank, and J Beyer
January 1954, Archives d'anatomie, d'histologie et d'embryologie normales et experimentales,
G Frank, and J Beyer
February 1953, Nature,
Copied contents to your clipboard!